- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05829174
Comparison of Online Group Therapy Interventions for Procrastination
November 28, 2024 updated by: Nencki Institute of Experimental Biology of the Polish Academy of Sciences
Comparison of Online Group Therapy Interventions for Procrastination: A Randomized Controlled Trial With Different Cognitive Behavior Therapy (CBT) Protocols
The aim of this study is to compare the efficacy of two cognitive behavior therapy (CBT) protocols for procrastination with an active control protocol including cognitive-behavioral elements and with a wait-list control group.
The interventions will be delivered online in group settings.
All three protocols include identical psychoeducation and cognitive modules related to procrastination, but will differ in the behavioral modules.
The behavioral module in one protocol is focused on starting on time and realistic planning.
The second protocol implements working time restriction.
The active comparator protocol implements the pomodoro time management technique.
The wait-list control group will receive one of the CBT protocols after the period of waiting.
It is assumed that all active conditions will be superior to the wait-list control, and that CBT protocols will be superior to the protocol including the time management technique.
Primary (procrastination) and secondary (depression and anxiety) measures will be collected prior and after the interventions (or waiting period in wait-list group) and after 6-months in the three active condition groups.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
222
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Warsaw, Poland, 02-093
- Nencki Institute of Experimental Biology, Polish Academy of Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Bachelor's and Master's university students
- Self-reported primary difficulties related to chronic and severe procrastination
- Serious procrastination problem lasting for at least one year as confirmed during clinical interview
- Having a postponed/procrastinated project to complete in the course of therapy
- Willing to participate in the study
- Fluent in Polish language
- Computer access and stable Internet connection
Exclusion Criteria:
- Current participation in other psychotherapy
- Change of psychiatric medication during last 12 weeks
- Severe anxiety or affective disorders and any other severe psychiatric disorders that require other type of specialized care and are primary to procrastination problem (e.g. major depressive episode, social phobia, PTSD, etc.)
- Active suicidality
- Psychosis, bipolar disorder
- Alcohol or substance dependence
- Severe personality disorders (with exclusion of avoidant, dependent and obsessive-compulsive personality disorders)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive Behavioral Therapy with Techniques of Starting on Time and Planning Realistically
5 session (one session a week) online group therapy including several psychoeducation and cognitive modules (what is procrastination, role of rewards, work environment, belief identification, cognitive restructuring, relapse prevention) and a behavioral module: realistic planning, timely beginning.
|
Psychoeducation and cognitive modules: what is procrastination, role of rewards, work environment, belief identification, cognitive restructuring, relapse prevention.
Learning of realistic planning, and timely starting of work.
|
|
Experimental: Cognitive Behavioral Therapy with Technique of Working Time Restriction
5 session (one session a week) online group therapy including several psychoeducation and cognitive modules (what is procrastination, role of rewards, work environment, belief identification, cognitive restructuring, relapse prevention) and a behavioral module: working time restriction.
|
Psychoeducation and cognitive modules: what is procrastination, role of rewards, work environment, belief identification, cognitive restructuring, relapse prevention.
Restriction of allowed time for work, and gradual increase of allowed time, if previous time windows where effectively used.
|
|
Active Comparator: Cognitive Behavioral Intervention with Time Management Technique
5 session (one session a week) online group therapy including several psychoeducation and cognitive modules (what is procrastination, role of rewards, work environment, belief identification, cognitive restructuring, relapse prevention) and a behavioral module: pomodoro technique.
|
Psychoeducation and cognitive modules: what is procrastination, role of rewards, work environment, belief identification, cognitive restructuring, relapse prevention.
Working in 25 minutes time intervals
|
|
No Intervention: Wait-list control group
No intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Polish version of the Pure Procrastination Scale (PPS)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
Assessment of procrastination level.
The Polish version of PPS consists of 12 items that evaluate procrastination conceptualized as a dysfunctional delay (e.g.
"I am continually saying I'll do it tomorrow"; "I delay making decisions until it's too late").
Participants respond on a 5-point scale (1 = "very seldom or not true of me"; 2 = "seldom true of me"; 3 = "sometimes true of me"; 4 = "often true of me"; 5 = "very often true of true of me")
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of the Aitken Procrastination Inventory (API)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
Assessment of academic procrastination level.
The Polish version of API consists of 19 items that evaluate the tendency of students to procrastinate in their academic tasks (e.g.
"If I had an important project to do, I'd get started on it as quickly as possible", "Getting down to work often takes me a long time.").
Participants respond on a 5-point scale (1 = "false"; 2 = "mostly false"; 3 = " sometimes false/sometimes true"; 4 = "mostly true"; 5 = "true").
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Polish version of the Patient Health Questionnaire (PHQ-9)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
Assessment of depressive symptoms.
The Polish version of PHQ-9 consists of 9 items that evaluate the occurrence of depressive symptoms in the last 2 weeks (e.g.
"Little interest or enjoyment of your activities").
Participants respond on a 4-point Likert scale (0 = "not at all"; 1 = "on a few days"; 2 = "on more than half of the days"; 3 = "nearly every day").
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of the Generalized Anxiety Disorder Questionnaire-7 (GAD-7)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
Assessment of depressive symptoms.
The Polish version of GAD-7 consists of 7 items that evaluate the occurrence of anxiety and excessive worry symptoms in the last 2 weeks (e.g.
"Feeling afraid as if something awful might happen").
Participants respond on a 4-point Likert scale (0 = "not at all"; 1 = "on a few days"; 2 = "on more than half of the days"; 3 = "nearly every day").
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Degree of completion of a particular project that the participant decided to work on during the training (e.g. a thesis, an essay, a report).
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6)
|
Before and after therapy participants will be asked to assess the degree of completion of this project in percents.
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6)
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Polish version of the Group Session Rating Scale (GSRS)
Time Frame: During the treatment (after each therapy session - weeks 1-5)
|
During the treatment (after each therapy session - weeks 1-5)
|
|
Polish version of the Credibility Expectancy Questionnaire (CEQ)
Time Frame: After the first session (week 1)
|
After the first session (week 1)
|
|
Polish version of the Negative Effects Questionnaire (NEQ)
Time Frame: Post-treatment (week 6)
|
Post-treatment (week 6)
|
|
Polish version of the Client Satisfaction Questionnaire (CSQ)
Time Frame: Post-treatment (week 6)
|
Post-treatment (week 6)
|
|
Change in Polish version of the subscales Low work discipline and Fear of failure of the Study Problems Questionnaire (SPQ)
Time Frame: baseline assessment (week 0) mid-treatment assessment (week 3);; post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0) mid-treatment assessment (week 3);; post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of the Sensitivity to Punishment and Sensitivity to Reward Questionnaire - Short Form (SPSRQ-SF)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of the Multidimensional-Multiattributional Causality Scale (MMCS)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of the Performance Failure Appraisal Inventory (PFAI)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of the Difficulties in Emotion Regulation questionnaire (DERS)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of the Motivation Diagnostic Test (MDT)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of the Zimbardo Time Perspective Inventory
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of the Metacognitive Beliefs about Procrastination Questionnaire (MBPQ)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of the Impulsivity Scale (UPPS-P)
Time Frame: baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0); mid-treatment assessment (week 3); post-treatment assessment (week 6); follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of the Self-control Scale (NAS-50)
Time Frame: baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6), follow-up assessment (6 months after post-treatment assessment)
|
|
Change in Polish version of Positive and Negative Affect Schedule (PANAS) in relation to a project that the participant decided to work on during the training (e.g. a thesis, an essay, a report)
Time Frame: baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6)
|
baseline assessment (week 0), mid-treatment assessment (week 3), post-treatment assessment (week 6)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Marek Wypych, PhD, DSc, Nencki Institute of Experimental Biology, Polish Academy of Sciences
- Principal Investigator: Jarosław Michałowski, Prof., SWPS University of Social Sciences and Humanities
- Principal Investigator: Joachim Kowalski, PhD, Institute of Psychology, Polish Academy of Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 14, 2023
Primary Completion (Actual)
June 15, 2024
Study Completion (Actual)
June 15, 2024
Study Registration Dates
First Submitted
April 12, 2023
First Submitted That Met QC Criteria
April 24, 2023
First Posted (Actual)
April 25, 2023
Study Record Updates
Last Update Posted (Actual)
December 3, 2024
Last Update Submitted That Met QC Criteria
November 28, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- NenckiInstitute
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Procrastination
-
Nencki Institute of Experimental Biology of the...Institute of Psychology, Polish Academy of Sciences; SWPS University of Social...Completed
-
OvercomeCompletedProcrastinationUnited Kingdom
-
University of BarcelonaTerminated
-
University of BathUppsala University; Linkoeping UniversityRecruitingProcrastinationUnited Kingdom
-
VU University of AmsterdamLeiden University; Maastricht University; Utrecht University; Erasmus University...Recruiting
-
Postgraduate Institute of Dental Sciences RohtakCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
London Metropolitan UniversityCompletedProcrastinationUnited Kingdom
-
Stockholm UniversityKarolinska InstitutetCompleted
-
Stockholm UniversityCompletedProcrastinationSweden
Clinical Trials on Psychoeducation and cognitive modules
-
Nencki Institute of Experimental Biology of the...Institute of Psychology, Polish Academy of Sciences; SWPS University of Social...Completed
-
NYU Langone HealthRecruitingTraumatic Brain InjuryUnited States
-
Hospital San Carlos, MadridCompleted
-
Medical College of WisconsinTerminatedNeurocognitive DisordersUnited States
-
Université de MontréalCentre de Recherche de l'Institut Universitaire en santé Mentale de MontréalCompleted
-
City University of Hong KongNot yet recruitingMild Cognitive Impairment (MCI)Hong Kong
-
University of GaziantepCompletedPsychoeducation StudyTurkey (Türkiye)
-
Florida State UniversityUnited States Department of DefenseCompletedDepression | Anxiety | SuicideUnited States
-
Florida State UniversityCompletedSuicide | Health Behavior | Help-Seeking BehaviorUnited States
-
Boston UniversityNational Institute of Mental Health (NIMH)CompletedStress Disorders, Post-TraumaticUnited States